Skyscape Web Viewer : Davis's Canadian Drug Guide for Nurses : Pharmacologic Index

View All
macrolides azithromycin erythromycin clarithromycin fidaxomicin
mast cell stabilizers
meglitinides nateglinide repaglinide
melanocortin receptor agonists afamelanotide setmelanotide bremelanotide
melatonin receptor agonists tasimelteon ramelteon
microsomal transfer protein inhibitors
minerals electrolytes fluoride supplements magnesium sulfate (parenteral)
monamine oxidase inhibitors isocarboxazid phenelzine moclobemide tranylcypromine
monoamine oxidase type b inhibitors rasagiline selegiline safinamide
monobactams aztreonam/avibactam aztreonam
monoclonal antibodies alemtuzumab amivantamab atezolizumab axatilimab belimumab bevacizumab blinatumomab caplacizumab certolizumab concizumab crovalimab daratumumab/hyaluronidase denosumab donanemab durvalumab elranatamab emicizumab erenumab evolocumab faricimab galcanezumab golimumab ibritumomab inebilizumab ipilimumab lanadelumab lecanemab margetuximab mogamulizumab naxitamab nirsevimab obinutuzumab ocrelizumab/hyaluronidase adalimumab alirocumab anifrolumab avelumab basiliximab benralizumab bimekizumab burosumab cemiplimab cetuximab crizanlizumab daratumumab datopotamab deruxtecan dinutuximab dostarlimab elotuzumab emapalumab eptinezumab evinacumab fam-trastuzumab deruxtecan fremanezumab gemtuzumab ozogamicin guselkumab idarucizumab infliximab isatuximab lebrikizumab loncastuximab tesirine mepolizumab natalizumab necitumumab nivolumab ocrelizumab ofatumumab pembrolizumab pertuzumab/trastuzumab/hyaluronidase ranibizumab reslizumab rituximab rozanolixizumab secukinumab talquetamab teprotumumab tildrakizumab trastuzumab/hyaluronidase ublituximab vedolizumab omalizumab pertuzumab polatuzumab vedotin ravulizumab risankizumab rituximab/hyaluronidase satralizumab tafasitamab teplizumab tezepelumab trastuzumab tremelimumab ustekinumab vilobelimab
Mechanistic target of rapamycin kinase inhibitors
metabolic inhibitors
mineralocorticoid receptor antagonists non steroidal
monoclonal anti-toxins obiltoxaximab raxibacumab
muscarinic agonists